Autism Speaks Launches Venture Philanthropy Arm
This article was originally published in The Pink Sheet Daily
Executive Summary
Autism Speaks, an advocacy group that has devoted nearly $200 million to basic research on autism spectrum disorders since 2005, is spinning out a venture arm called Delivering Scientific Innovation for Autism to fund efforts by the for-profit sector. The amount of funding involved is “not insignificant,” said Robert Ring, who left Pfizer in 2011 to spearhead the move into the transitional space.
You may also be interested in...
MedImmune Turns To Venture Philanthropy For Cancer ImmunoRx Combination Trials
MedImmune and two non-profit research organizations are collaborating on clinical trials that explore the tricky world of combinations of novel cancer immunotherapies, including three MedImmune compounds in different stages of development.
With Capital Scarce, Charities Emerge as a Stronger Force on Start-Up Scene
Disease-oriented foundations and cash-strapped biotechs are increasingly seeking common ground: as more becomes known about the mechanisms by which a given disease operates, foundation boards are finding more opportunities to fund promising start-ups and established biotechs.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.